Skip to main content
Clinical Trials/NCT06512181
NCT06512181
Recruiting
Not Applicable

Uterine Preservation in the Management of Placenta Accreta Spectrum Disorders

University of Pennsylvania1 site in 1 country15 target enrollmentApril 21, 2025

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Placenta Accreta Spectrum
Sponsor
University of Pennsylvania
Enrollment
15
Locations
1
Primary Endpoint
Hysterectomy rate
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

This study for the conservative management of placenta accreta spectrum disorders (PAS), which are a major cause of maternal morbidity and mortality. The most common management strategy for PAS in the United States is a preterm cesarean-hysterectomy. However, accumulating data show that conservative management is safer and is preferred by some patients. In selected participants (n=15) who desire uterine preservation, the investigators provide the option of conservative management, which will be defined as leaving the placenta in the uterus after delivery of the infant. This is a single-arm single-site pilot study where all participants will be carefully monitored during a standard postpartum inpatient stay and with outpatient follow-up until the uterus is empty.

Registry
clinicaltrials.gov
Start Date
April 21, 2025
End Date
December 31, 2030
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Beth Pineles

Assistant Professor of Obstetrics and Gynecology,Assistant Professor of Obstetrics and Gynecology in Biostatistics and Epidemiology

University of Pennsylvania

Eligibility Criteria

Inclusion Criteria

  • Provision of signed and dated informed consent form.
  • Stated willingness to comply with all study procedures and availability for the duration of the study.
  • A person with a uterus, age 18 or older
  • Currently 16-36 weeks pregnant with an intrauterine gestation
  • History of cesarean delivery AND placenta previa OR anterior low-lying placenta AND suspected of having PAS on prenatal imaging (ultrasound/MRI)
  • Patients for whom the usual management would be cesarean-hysterectomy.
  • Patient desires uterine preservation
  • Agreement to adhere to Lifestyle Considerations (see section 5.3) throughout study duration.

Exclusion Criteria

  • Have a low antenatal suspicion for PAS based on imaging.

Outcomes

Primary Outcomes

Hysterectomy rate

Time Frame: Delivery through 1 year

Percent of participants who undergo a hysterectomy

Secondary Outcomes

  • Endometritis rate(Delivery through 1 year)
  • Frequency of vaginal bleeding(Delivery through 1 year)
  • Frequency of pelvic pain(Delivery through 1 year)
  • Coagulopathy rate(Delivery through 1 year)

Study Sites (1)

Loading locations...

Similar Trials